AU2001269077A1 - Methods and means for regulation of gene expression - Google Patents
Methods and means for regulation of gene expressionInfo
- Publication number
- AU2001269077A1 AU2001269077A1 AU2001269077A AU6907701A AU2001269077A1 AU 2001269077 A1 AU2001269077 A1 AU 2001269077A1 AU 2001269077 A AU2001269077 A AU 2001269077A AU 6907701 A AU6907701 A AU 6907701A AU 2001269077 A1 AU2001269077 A1 AU 2001269077A1
- Authority
- AU
- Australia
- Prior art keywords
- regulation
- methods
- gene expression
- gene
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000014493 regulation of gene expression Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0015119.1A GB0015119D0 (en) | 2000-06-20 | 2000-06-20 | Methods and means for regulation of gene expression |
GB0015119 | 2000-06-20 | ||
PCT/EP2001/006792 WO2001098506A2 (en) | 2000-06-20 | 2001-06-15 | Methods and means for regulation of gene expression |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001269077A1 true AU2001269077A1 (en) | 2002-01-02 |
Family
ID=9894063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001269077A Abandoned AU2001269077A1 (en) | 2000-06-20 | 2001-06-15 | Methods and means for regulation of gene expression |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030109678A1 (en) |
EP (1) | EP1297161A2 (en) |
JP (1) | JP2004500884A (en) |
AU (1) | AU2001269077A1 (en) |
CA (1) | CA2413468A1 (en) |
GB (1) | GB0015119D0 (en) |
WO (1) | WO2001098506A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7723102B2 (en) | 2000-09-28 | 2010-05-25 | Bayer Corporation | Enhanced transfection system |
BR112015022978A8 (en) * | 2013-03-15 | 2018-01-23 | Memorial Sloan Kettering Cancer Center | multimerization technologies |
KR102509481B1 (en) * | 2014-04-10 | 2023-03-10 | 시애틀 칠드런즈 호스피탈 디/비/에이 시애틀 칠드런즈 리서치 인스티튜트 | Defined composition gene modified t-cell products |
CN108174604B (en) | 2015-08-07 | 2023-06-23 | 西雅图儿童医院(Dba西雅图儿童研究所) | Bispecific CAR T cells for solid tumor targeting |
CN110291200B (en) | 2016-12-12 | 2024-05-14 | 西雅图儿童医院(Dba西雅图儿童研究所) | Agent ligand induction of transgene expression in mammalian cells |
US11325957B2 (en) | 2017-06-19 | 2022-05-10 | Cell Design Labs, Inc. | Methods and compositions for reducing the immunogenicity of chimeric notch receptors |
KR102109820B1 (en) * | 2018-04-16 | 2020-05-12 | 한양대학교 산학협력단 | Mutant estrogen receptor protein having improved binding capacity for Bisphenol A and bacterial strain using the same |
CN114106123B (en) * | 2021-11-22 | 2023-03-14 | 四川农业大学 | Transcriptional activation domain TaL and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0805819B1 (en) * | 1994-12-29 | 2012-02-08 | Massachusetts Institute Of Technology | Chimeric dna-binding proteins |
US6303319B1 (en) * | 1996-02-23 | 2001-10-16 | Ariad Pharmaceuticals, Inc. | Cell based assay for identifying sh2-domain-specific signal transducer antagonist |
-
2000
- 2000-06-20 GB GBGB0015119.1A patent/GB0015119D0/en not_active Ceased
-
2001
- 2001-06-15 US US10/312,170 patent/US20030109678A1/en not_active Abandoned
- 2001-06-15 JP JP2002504654A patent/JP2004500884A/en not_active Withdrawn
- 2001-06-15 WO PCT/EP2001/006792 patent/WO2001098506A2/en not_active Application Discontinuation
- 2001-06-15 AU AU2001269077A patent/AU2001269077A1/en not_active Abandoned
- 2001-06-15 CA CA002413468A patent/CA2413468A1/en not_active Abandoned
- 2001-06-15 EP EP01947373A patent/EP1297161A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2004500884A (en) | 2004-01-15 |
WO2001098506A3 (en) | 2002-04-25 |
GB0015119D0 (en) | 2000-08-09 |
EP1297161A2 (en) | 2003-04-02 |
WO2001098506A2 (en) | 2001-12-27 |
CA2413468A1 (en) | 2001-12-27 |
US20030109678A1 (en) | 2003-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001234608A1 (en) | Methods for analysis of gene expression | |
AU2002253836A1 (en) | Aptamer-mediated regulation of gene expression | |
EP1177277A4 (en) | Compositions and methods for the modification of gene transcription | |
AU2002212963A1 (en) | Method of and structure for controlling electrode temperature | |
AU2001253255A1 (en) | Compositions and methods for inhibiting gene expression | |
AU2001245987A1 (en) | Compositions and methods for gene therapy | |
AU1723001A (en) | Methods and means for regulation of gene expression | |
AU2001269077A1 (en) | Methods and means for regulation of gene expression | |
AU2002222618A1 (en) | Method of analyzing gene expression | |
AU6469699A (en) | Method of regulating gene expression | |
AU2001251138A1 (en) | Compositions and methods for tissue specific gene regulation therapy | |
AU2841500A (en) | Dehiscence gene and methods for regulating dehiscence | |
AU2002219992A1 (en) | Targeted regulation of gene expression | |
EP1163340A4 (en) | Compositions and methods for the modification of gene expression | |
AU2001274080A1 (en) | Regulation of human transketolase-like enzyme | |
AU2002355155A1 (en) | Methods for gene disruption and uses thereof | |
AU7099400A (en) | Methods and reagents for regulating gene expression | |
AU2002222693A1 (en) | Method of concentrating gene | |
AU2001275487A1 (en) | Regulation of the p21 gene and uses thereof | |
AU2002245039A1 (en) | Genetic typing of human genes and related materials and methods | |
AU2002210525A1 (en) | Regulation of human phospholipase-like enzyme | |
AU2001281969A1 (en) | Regulation of human carboxylesterase-like enzyme | |
AU2001285782A1 (en) | Regulation of human phosphodiesterase-like enzyme | |
AU2002215942A1 (en) | Regulation of human carboxylesterase-like enzyme | |
AU1222601A (en) | Regulation of gene expression by neuromodulators |